Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2005 2
2006 2
2007 8
2008 7
2009 8
2010 8
2011 1
2012 2
2013 7
2014 11
2015 12
2016 6
2017 6
2018 10
2019 9
2020 14
2021 16
2022 9
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedure.
Roeder F, Fastner G, Fussl C, Sedlmayer F, Stana M, Berchtold J, Jäger T, Presl J, Schredl P, Emmanuel K, Colleselli D, Kotolacsi G, Scherer P, Steininger P, Gaisberger C. Roeder F, et al. Among authors: sedlmayer f. Radiat Oncol. 2023 Nov 10;18(1):186. doi: 10.1186/s13014-023-02374-6. Radiat Oncol. 2023. PMID: 37950314 Free PMC article.
Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?
Berchtold J, Winkler C, Karner J, Groher M, Gaisberger C, Sedlmayer F, Wolf F. Berchtold J, et al. Among authors: sedlmayer f. Strahlenther Onkol. 2024 Mar;200(3):195-201. doi: 10.1007/s00066-023-02125-2. Epub 2023 Aug 25. Strahlenther Onkol. 2024. PMID: 37626226 Free PMC article.
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Grambozov B, Kalantari F, Beheshti M, Stana M, Karner J, Ruznic E, Zellinger B, Sedlmayer F, Rinnerthaler G, Zehentmayr F. Grambozov B, et al. Among authors: sedlmayer f. Radiother Oncol. 2023 Aug;185:109728. doi: 10.1016/j.radonc.2023.109728. Epub 2023 Jun 9. Radiother Oncol. 2023. PMID: 37301259 Free article.
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.
Wass R, Hochmair M, Kaiser B, Grambozov B, Feurstein P, Weiß G, Moosbrugger R, Sedlmayer F, Lamprecht B, Studnicka M, Zehentmayr F. Wass R, et al. Among authors: sedlmayer f. Cancers (Basel). 2022 Jun 30;14(13):3226. doi: 10.3390/cancers14133226. Cancers (Basel). 2022. PMID: 35804997 Free PMC article.
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases.
Müller AC, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Ghadjar P, Schmidt-Hegemann NS, Höcht S, Hölscher T, Niehoff P, Pinkawa M, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T; Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO). Müller AC, et al. Among authors: sedlmayer f. Strahlenther Onkol. 2022 Aug;198(8):683-689. doi: 10.1007/s00066-022-01961-y. Epub 2022 Jun 15. Strahlenther Onkol. 2022. PMID: 35704054 Free PMC article. Review.
Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III.
Stana M, Grambozov B, Gaisberger C, Karner J, Ruznic E, Berchtold J, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Stana M, et al. Among authors: sedlmayer f. Diagnostics (Basel). 2022 Apr 19;12(5):1027. doi: 10.3390/diagnostics12051027. Diagnostics (Basel). 2022. PMID: 35626183 Free PMC article.
Oligometastasis in breast cancer-current status and treatment options from a radiation oncology perspective.
Piroth MD, Krug D, Feyer P, Baumann R, Combs S, Duma MN, Dunst J, Fastner G, Fietkau R, Guckenberger M, Haase W, Harms W, Hehr T, Sedlmayer F, Souchon R, Strnad V, Budach W. Piroth MD, et al. Among authors: sedlmayer f. Strahlenther Onkol. 2022 Jul;198(7):601-611. doi: 10.1007/s00066-022-01938-x. Epub 2022 May 8. Strahlenther Onkol. 2022. PMID: 35527272 Free PMC article. Review.
Long-Term Results of the TARGIT-A Trial: More Questions than Answers.
Piroth MD, Strnad V, Krug D, Fastner G, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Sedlmayer F, Souchon R, Budach W. Piroth MD, et al. Among authors: sedlmayer f. Breast Care (Basel). 2022 Feb;17(1):81-84. doi: 10.1159/000515386. Epub 2021 Apr 6. Breast Care (Basel). 2022. PMID: 35355706 Free PMC article. Review.
128 results